HUP0100781A3 - Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia and pharmaceutical compositions containing them - Google Patents

Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia and pharmaceutical compositions containing them

Info

Publication number
HUP0100781A3
HUP0100781A3 HU0100781A HUP0100781A HUP0100781A3 HU P0100781 A3 HUP0100781 A3 HU P0100781A3 HU 0100781 A HU0100781 A HU 0100781A HU P0100781 A HUP0100781 A HU P0100781A HU P0100781 A3 HUP0100781 A3 HU P0100781A3
Authority
HU
Hungary
Prior art keywords
treatment
pharmaceutical compositions
compositions containing
benign prostatic
prostatic hyperplasia
Prior art date
Application number
HU0100781A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HUP0100781A2 publication Critical patent/HUP0100781A2/hu
Publication of HUP0100781A3 publication Critical patent/HUP0100781A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU0100781A 1998-02-20 1999-02-19 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia and pharmaceutical compositions containing them HUP0100781A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (2)

Publication Number Publication Date
HUP0100781A2 HUP0100781A2 (hu) 2001-08-28
HUP0100781A3 true HUP0100781A3 (en) 2002-12-28

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100781A HUP0100781A3 (en) 1998-02-20 1999-02-19 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6218396B1 (https=)
EP (1) EP1054868B1 (https=)
JP (1) JP2002503724A (https=)
KR (1) KR100591028B1 (https=)
CN (1) CN1121390C (https=)
AR (1) AR014626A1 (https=)
AT (1) ATE250580T1 (https=)
AU (1) AU766398B2 (https=)
BR (1) BR9909647A (https=)
CZ (1) CZ294136B6 (https=)
DE (1) DE69911582T2 (https=)
DK (1) DK1054868T3 (https=)
ES (1) ES2209468T3 (https=)
HU (1) HUP0100781A3 (https=)
IL (2) IL137954A0 (https=)
NO (1) NO317103B1 (https=)
NZ (1) NZ506462A (https=)
PL (1) PL342339A1 (https=)
PT (1) PT1054868E (https=)
TR (1) TR200003220T2 (https=)
TW (1) TW565555B (https=)
WO (1) WO1999042448A1 (https=)
ZA (1) ZA991315B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001904B1 (ru) * 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты
CZ2003686A3 (cs) 2000-08-08 2003-08-13 Ortho Mcneil Pharmaceutical, Inc. Neimidazolové aryloxypiperidiny
KR20060005009A (ko) 2001-12-28 2006-01-16 다케다 야쿠힌 고교 가부시키가이샤 배뇨 장애 예방제/치료제
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
CL2009000964A1 (es) * 2008-04-23 2010-03-26 Takeda Pharmaceuticals Co Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior.
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine

Also Published As

Publication number Publication date
HK1030776A1 (en) 2001-05-18
DE69911582D1 (de) 2003-10-30
BR9909647A (pt) 2000-11-21
IL137954A (en) 2007-06-03
EP1054868A1 (en) 2000-11-29
AU3302599A (en) 1999-09-06
CN1291188A (zh) 2001-04-11
ES2209468T3 (es) 2004-06-16
NZ506462A (en) 2003-07-25
ZA991315B (en) 2000-11-20
NO20004141L (no) 2000-10-19
IL137954A0 (en) 2001-10-31
DE69911582T2 (de) 2005-09-15
EP1054868B1 (en) 2003-09-24
CZ294136B6 (cs) 2004-10-13
KR20010041115A (ko) 2001-05-15
DK1054868T3 (da) 2003-12-22
US6218396B1 (en) 2001-04-17
WO1999042448A1 (en) 1999-08-26
ATE250580T1 (de) 2003-10-15
AU766398B2 (en) 2003-10-16
HUP0100781A2 (hu) 2001-08-28
PL342339A1 (en) 2001-06-04
PT1054868E (pt) 2004-01-30
CN1121390C (zh) 2003-09-17
NO317103B1 (no) 2004-08-09
TR200003220T2 (tr) 2001-04-20
AR014626A1 (es) 2001-03-28
TW565555B (en) 2003-12-11
KR100591028B1 (ko) 2006-06-22
CZ20003044A3 (cs) 2001-04-11
NO20004141D0 (no) 2000-08-18
JP2002503724A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
HUP0103575A3 (en) Inhibitors of caspases, pharmaceutical compositions comprising thereof and their use
IL142770A0 (en) Pharmaceutical compositions containing poly (adp-ribose) glycohydrolase inhibitors and methods of using the same
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
HUP0104496A3 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions
HUP9903732A3 (en) Use of cgmp elevators for the preparation of pharmaceutical compositions treating benign prostatic hyperplasia
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
HUP0100781A3 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia and pharmaceutical compositions containing them
HUT73678A (en) Compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
HUP0100048A3 (en) Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
GB2331926B (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AP2000001950A0 (en) Paroxetine maleate.
IL137953A0 (en) Phthalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
IT1283124B1 (it) Forme e composizioni farmaceutiche per il trattamento dell'ipertrofia prostatica benigna
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
GB9821537D0 (en) Pharmaceutical compositions and their use
GB9827835D0 (en) Pharmaceutical compositions and their use
GB9824393D0 (en) Pharmaceutical compositions and their uses
PL337123A1 (en) Disinfecting compositions and methods of disinfecting surfaces

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees